Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Several possible studies

Story checked

Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins (opens in a new tab)

news-medical.net · 2026-11-03

Short answerEvidenceSource

Short answer

Several possible studies

Study not confirmed.

Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.

16 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Multiple potential source studies identified.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

View article claims
3

Search result

Several studies could fit.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

  • Points somewhere elsepresented as the new finding

    https://www.fusfoundation.org/posts/reducing-hallucinations-in-schizophrenia-with-focused-ultrasound-first-in-human-clinical-trial-begins/

    Where the story links (opens in a new tab)
  • Cited as backgroundpresented as earlier work

    https://www.news-medical.net/news/20261030/Researchers-test-noninvasive-ultrasound-treatment-for-schizophrenia-related-hallucinations.aspx

    Where the story links (opens in a new tab)
The literature search

16 candidate papers

Studies identified during the search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 12 more search results
Then inspect each claim

Evidence layer

Claim by claim

The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.

Claim 1 of 5Not checkedAuditory hallucinations affect more than 70% of people with schizophrenia, and about 40% continue to experience persistent hallucinations despite antipsychotic treatment.View evidenceHide evidence

As statedmore than 70%; approximately 40%

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 2 of 5Not checkedUCSF has launched a first-in-human Phase 1 clinical trial to evaluate the safety and feasibility of repeated low-intensity focused ultrasound sessions targeting the caudate to reduce hallucinations in schizophrenia.View evidenceHide evidence

As statedfirst-in-human; Phase 1; up to 12 participants

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 3 of 5Not checkedThe trial is studying repeated daily active LIFU sessions versus sham control, with resting-state fMRI and clinical outcome measures used to assess effects on hallucination severity, other psychiatric symptoms, mood, safety, and tolerability.View evidenceHide evidence

As statedfive daily sessions of active LIFU and five sessions of sham control

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 4 of 5Not checkedThe story says the trial builds on encouraging preliminary findings published in Brain Stimulation, which showed that a single session of LIFU produced significant, albeit temporary, reductions in hallucinations.View evidenceHide evidence

As statedsingle session; significant but temporary reductions

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 5 of 5Not checkedInitial participants in the ongoing trial reportedly described reductions in hallucinations after repeated LIFU, but the article says these early observations are preliminary and encouraging.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Finally, the search trail

Method layer

Study not confirmed.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

First-in-human low-intensity focused ultrasound targeting striatal circuits in schizophrenia: feasibility, safety, and effects on hallucinations and striatal-temporal functional connectivity.

medRxiv : the Preprint Server for Health Sciences · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

Explore all search results